Health Guidelines for Advanced Maternal Age Pregnancy
Modern women increasingly marry later and delay childbearing, compounded by evolving disease patterns, environmental changes, and unhealthy lifestyles—all heightening risks during pregnancy.Therefore, prenatal health care for these mature expectant mothers is increasingly crucial. How to protect both the mother and the developing baby during pregnancy, thereby laying a solid foundation for this new life, is a matter of concern for modern parents.
The fundamentals of prenatal checkups must not be overlooked.
Thanks to scientific advancements and improvements in medical diagnostic equipment and techniques, the risks women face during pregnancy and childbirth are significantly lower than in the past. However, prenatal checkups remain indispensable! Comprehensive prenatal examinations enable early detection of abnormalities in both the mother and fetus, allowing timely intervention to safeguard the health of both.
At the first prenatal visit, the hospital or clinic will provide a "Maternal Health Handbook," which should be brought to all subsequent appointments. Medical staff will record detailed examination results in this handbook. The full series of prenatal checkups consists of 15 visits.
Examinations occur every 4 weeks until week 28 of pregnancy, every 2 weeks from weeks 29 to 36, and weekly after week 37.Pregnant women with high-risk pregnancies or pregnancy complications may require additional checkups based on their specific circumstances.
Thalassemia Screening for Pregnant Women
Thalassemia is a single-gene hereditary disease common in Taiwan, typically categorized into two types: alpha and beta. Approximately 6% of the population are beta carriers, whose physical condition is generally similar to that of the general population.If both parents are homozygous carriers, each pregnancy carries a 25% chance of a normal fetus, a 50% chance of a carrier, and a 25% chance of a severe carrier. Severe carriers pose a threat to the life and health of both the mother and fetus."Mean Corpuscular Volume" (MCV). If the mother's MCV is ≤80, the father's blood should be further tested. If both parents have MCV ≤80, their blood samples should be sent to a Department of Health-accredited genetic testing facility to determine the thalassemia carrier pattern. Couples who are homozygous carriers should undergo fetal thalassemia genetic confirmation testing for each pregnancy to determine the baby's health status early.
Women aged 34 and above constitute a high-risk group for giving birth to children with Down syndrome. The probability of chromosomal abnormalities increases with maternal age. Taking the natural incidence of Down syndrome as an example, approximately one in every thousand newborns may have Down syndrome. For a 34-year-old pregnant woman, the probability is approximately one in every three hundred births.Medical advances now allow early confirmation through amniocentesis, preventing couples from unknowingly giving birth to a child with defects.
The optimal time for amniocentesis is between 16 and 18 weeks of pregnancy. Under ultrasound guidance and monitoring, a long needle is used to extract a small amount of amniotic fluid through the abdomen, uterus, and amniotic sac to test the fetus's chromosomes for abnormalities. Results are typically available in 3 to 4 weeks.
It is important to note that not every pregnant woman requires this procedure. It is only warranted when the risk of the fetus having a congenital abnormality exceeds the risk of complications from the amniocentesis itself. If the sole purpose is to determine the fetus's gender, it does not align with the intended purpose of the test.Before undergoing sampling, expectant mothers should fully understand the purpose, safety, success rates, and potential complications of each test to alleviate unnecessary psychological barriers. Amniocentesis involves withdrawing several milliliters of amniotic fluid produced during pregnancy using a simple instrument under sterile conditions for laboratory analysis to assess fetal health. This procedure is ideally performed between 15 and 16 weeks of gestation.Performing it too early may result in insufficient amniotic fluid, making sample collection difficult and increasing the risk of fetal injury. Delaying the procedure until later stages, when the fetus is fully developed, complicates termination if abnormalities are detected, as it increases both procedural difficulty and maternal risk.
Why Older Fathers Are Prone to Having Children with Autism Why Older Mothers Are Prone to Having Children with Intellectual Disabilities Older Mothers Need Amniocentesis Diagnosis
Key Points of Amniocentesis Technique
1.For suitable pregnant women, determine the abdominal puncture site using ultrasound guidance or perform the procedure under ultrasound monitoring;
2. Before amniocentesis, have the patient lie down and roll over five times consecutively to suspend fetal cells in the amniotic fluid, facilitating the collection of more fetal cells.
3. Sterilize the puncture site with a sterile kit according to aseptic technique, drape the area, and use a puncture needle to withdraw 10-20 mL of amniotic fluid. Slowly inject the fluid along the tube wall into a sterile centrifuge tube and seal it with a sterile cap;
4. Centrifuge routinely. Open the seal under sterile conditions, discard the supernatant, and retain approximately 1 mL of amniotic fluid. Mix the cell pellet to form a cell suspension for genetic testing or cell culture;
5. Transfer 1 mL of the cell suspension prepared for genetic testing into a pre-prepared 1.5 mL sterile plastic centrifuge tube with a screw cap;Seal the tube and ship it to the testing facility along with the pregnant woman's detailed testing records, packed with ice packs. Upon receipt, the facility will archive the sample and perform genetic testing.
6. For cell culture, evenly distribute the suspension into prepared culture flasks. Sterilely seal and incubate in a CO₂ incubator. Observe growth every few days under an inverted microscope, replacing part of the medium as needed. After 15-20 days of culture, when cells cover the flask walls, harvest them for chromosome analysis.